CIMBID Seminar
The CIMBID seminar series features both internal and external faculty speakers, industry professionals, and broader experts to deliver lectures on topics related to CIMBID’s mission and research innovation. CIMBID seminars are offered with both in-person and virtual options and are open to the Columbia community.
Upcoming CIMBID Seminars
Seminars will be held monthly beginning in September 2025 in the Radiology conference room, PH1-317. Please check back for the full schedule.
August 22, 2025
Hamilton Oh, PhD
Postdoctoral Researcher
Mt. Sinai Medicine
Please check back for the link to attend this seminar virtually.
Past Seminars
Watch our past lectures with the video link provided.
May 5, 2025 - Ye Ella Tian, PhD
Understanding Mental-Physical Comorbidity via Integrated Modeling of Brain-Body Axis
Ye Ella Tian, PhD
NHMRC Emerging Leadership Fellow
Senior Leadership Fellow
Department of Psychiatry
The University of Melbourne
March 20, 2025 - Thomas Yankeelov, PhD
Personalizing Interventions Through Imaging-based Digital Twins
Thomas Yankeelov, PhD
Professor, Director of Center for Computational Oncology
W. A. "Tex" Moncrief, Jr. Chair in Computational Engineering and Sciences IV - Computational Oncology
University of Texas at Austin
Cockrell School of Engineering
Our lab focuses on developing tumor forecasting methods by integrating medical imaging data with biology-based, mathematical models to predict tumor growth and treatment response on an individual patient basis. These data are acquired before therapy begins, and again at one or more time points during therapy. All model parameters that are not directly measured are calibrated to the longitudinal imaging data from a patient. Then, the personalized model is run forward to predict tumor size and other characteristics of the patient’s tumor at future times which can be directly tested against observation and, ultimately, guide intervention. In this presentation, we will provide an overview of this effort through four vignettes focusing on 1) incorporating patient-specific data into biology-based mathematical models, 2) simulating outcomes via digital twins, 3) guiding interventions through optimal control theory, and 4) updating interventions through data assimilation. To tell a complete story we will focus on breast cancer, but also summarize our efforts in brain, cervical, and prostate cancer.
November 7, 2024 - Pallavi Tiwari, PhD
Artificial Intelligence and Computational Imaging: Opportunities for Precision Medicine in Oncology and Neurological Disorders
Pallavi Tiwari, PhD
Associate Professor
Departments of Radiology & Biomedical Engineering
University of Wisconsin, Madison
Co-Director, Imaging & Radiation Sciences Program
Carbone Cancer Center
September 25, 2024 - Ipek Oguz, PhD
Medical Image Segmentation and Synthesis
Ipek Oguz, PhD
Associate Professor
Department of Computer Science
Vanderbilt University
September 10, 2024 - Prateek Prasanna, PhD
Collaborative Medical Vision for Precision Medicine
Prateek Prasanna, PhD
Assistant Professor
Department of Biomedical Informatics
Stony Brook University
July 31, 2024 - Junhao Wen, PhD
Reflection on Precision Medicine in the Era of AI/ML: Reproducibility, Disease Heterogeneity, and Multi-Scale Modeling
Junhao (Hao) Wen, PhD
Assistant Professor and PI
LABS at the University of Southern California
Abstract: Dr. Wen’s research endeavors focus on developing and applying artificial intelligence and machine learning (AI/ML) techniques to analyze multi-organ, multi-omics biomedical data for studying human aging and disease. This talk encompasses three intertwined yet progressive perspectives: i) scrutinizing the reproducibility of AI/ML in neuroimaging research; ii) depicting the neuroanatomical heterogeneity of brain disorders using AI/ML and imaging; and iii) embracing multi-scale (organs and omics) approaches to investigate human aging and disease beyond the brain. Integrating AI-driven decision support systems into clinical settings to identify potential genetic, proteomic, metabolomics, and imaging biomarkers for future therapeutic interventions is central to his research interests.